Limited coverage criteria – goserelin

Last updated on March 18, 2025

 

Return to Special Authority drug list 

Generic name

goserelin

Special Authority criteria

Approval period

Diagnosis of endometriosis Initial approval: 6 months

Renewal: 6 months

Practitioner exemptions

  • None

Special notes

  • For any cancer-related condition, please contact the British Columbia Cancer Agency at (604) 877-6098 ext. 4610

Special Authority request form(s)